Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Northwest Biotherapeutics (NWBO) Receivables - Other (2016)

Northwest Biotherapeutics (NWBO) has 5 years of Receivables - Other data on record, last reported at $700000.0 in Q3 2016.

  • For Q3 2016, Receivables - Other fell 41.67% year-over-year to $700000.0; the TTM value through Sep 2016 reached $700000.0, down 41.67%, while the annual FY2015 figure was $1.2 million, N/A changed from the prior year.
  • Receivables - Other reached $700000.0 in Q3 2016 per NWBO's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $4.8 million in Q3 2012 and bottomed at $700000.0 in Q3 2016.
  • Average Receivables - Other over 4 years is $2.0 million, with a median of $1.2 million recorded in 2015.
  • Peak YoY movement for Receivables - Other: tumbled 54.29% in 2015, then plummeted 41.67% in 2016.
  • A 4-year view of Receivables - Other shows it stood at $4.8 million in 2012, then plummeted by 45.31% to $2.6 million in 2014, then crashed by 54.29% to $1.2 million in 2015, then plummeted by 41.67% to $700000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $700000.0 in Q3 2016, $1.0 million in Q2 2016, and $1.0 million in Q1 2016.